HPGC Renmintongtai Pharmaceutical Corp Asset Resilience Ratio

Latest as of September 2010: 0.00%

HPGC Renmintongtai Pharmaceutical Corp asset resilience ratio. HPGC Renmintongtai Pharmaceutical Corp (600829) has an Asset Resilience Ratio of 0.00% as of September 2010. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HPGC Renmintongtai Pharmaceutical Corp (600829) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥8.20K
≈ $1.20K USD Cash + Short-term Investments

Total Assets

CN¥3.30 Billion
≈ $482.91 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of HPGC Renmintongtai Pharmaceutical Corp (1995–2009)

Asset resilience ratio of HPGC Renmintongtai Pharmaceutical Corp from 1995 to 2009. This chart shows how HPGC Renmintongtai Pharmaceutical Corp's Asset Resilience Ratio has changed over time. Read HPGC Renmintongtai Pharmaceutical Corp (600829) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down HPGC Renmintongtai Pharmaceutical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see HPGC Renmintongtai Pharmaceutical Corp (600829) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥8.20K 0.0%
Total Liquid Assets CN¥8.20K 0.00%

Asset Resilience Insights

  • Limited Liquidity: HPGC Renmintongtai Pharmaceutical Corp maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

HPGC Renmintongtai Pharmaceutical Corp Industry Peers by Asset Resilience Ratio

Compare HPGC Renmintongtai Pharmaceutical Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Ajanta Pharma Limited
NSE:AJANTPHARM
Drug Manufacturers - Specialty & Generic 14.99%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
Drug Manufacturers - Specialty & Generic 26.45%
Porton Fine Chemicals Ltd
SHE:300363
Drug Manufacturers - Specialty & Generic 6.85%
Jubilant Pharmova Limited
NSE:JUBLPHARMA
Drug Manufacturers - Specialty & Generic 1.26%

HPGC Renmintongtai Pharmaceutical Corp Asset Resilience Ratio by Year (1995–2009)

HPGC Renmintongtai Pharmaceutical Corp asset resilience ratio by year from 1995 to 2009. The table below shows the annual Asset Resilience Ratio data for HPGC Renmintongtai Pharmaceutical Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2009-12-31 0.00% CN¥65.16K
≈ $9.53K
CN¥2.85 Billion
≈ $417.56 Million
0.00pp
2008-12-31 0.00% CN¥87.24K
≈ $12.77K
CN¥2.91 Billion
≈ $426.49 Million
-0.22pp
2007-12-31 0.22% CN¥5.85 Million
≈ $856.25K
CN¥2.68 Billion
≈ $392.22 Million
+0.13pp
2006-12-31 0.09% CN¥2.00 Million
≈ $292.85K
CN¥2.24 Billion
≈ $327.69 Million
+0.08pp
2003-12-31 0.00% CN¥53.00K
≈ $7.76K
CN¥1.08 Billion
≈ $157.58 Million
+0.00pp
2002-12-31 0.00% CN¥1.00K
≈ $146.33
CN¥929.89 Million
≈ $136.07 Million
-2.00pp
2000-12-31 2.00% CN¥20.00 Million
≈ $2.93 Million
CN¥1.00 Billion
≈ $146.49 Million
-1.67pp
1999-12-31 3.66% CN¥26.00 Million
≈ $3.80 Million
CN¥709.69 Million
≈ $103.85 Million
-0.05pp
1998-12-31 3.72% CN¥25.00 Million
≈ $3.66 Million
CN¥672.44 Million
≈ $98.40 Million
+0.69pp
1997-12-31 3.03% CN¥20.23 Million
≈ $2.96 Million
CN¥667.48 Million
≈ $97.67 Million
-0.17pp
1996-12-31 3.20% CN¥20.69 Million
≈ $3.03 Million
CN¥646.29 Million
≈ $94.57 Million
-0.98pp
1995-12-31 4.18% CN¥26.50 Million
≈ $3.88 Million
CN¥634.21 Million
≈ $92.81 Million
--
pp = percentage points

About HPGC Renmintongtai Pharmaceutical Corp

SHG:600829 China Drug Manufacturers - Specialty & Generic
Market Cap
$734.85 Million
CN¥5.02 Billion CNY
Market Cap Rank
#9952 Global
#2585 in China
Share Price
CN¥8.66
Change (1 day)
-3.13%
52-Week Range
CN¥7.76 - CN¥17.72
All Time High
CN¥17.72
About

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosm… Read more